{"protocolSection":{"identificationModule":{"nctId":"NCT03772457","orgStudyIdInfo":{"id":"InV HT RAF 1010"},"organization":{"fullName":"Second Affiliated Hospital, School of Medicine, Zhejiang University","class":"OTHER"},"briefTitle":"Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban","officialTitle":"To Explore the Predictive Value of Infarction Volume on Hemorrhagic Transformation in Newly Diagnosed Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban"},"statusModule":{"statusVerifiedDate":"2023-04","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2019-01-18","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2017-10-10","studyFirstSubmitQcDate":"2018-12-09","studyFirstPostDateStruct":{"date":"2018-12-11","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-04-16","lastUpdatePostDateStruct":{"date":"2023-04-18","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","class":"OTHER"},"collaborators":[{"name":"Bayer","class":"INDUSTRY"},{"name":"Taizhou Hospital","class":"OTHER"},{"name":"Zhuji People's hospital","class":"UNKNOWN"},{"name":"Shaoxing People's Hospital","class":"OTHER"},{"name":"Jinhua Central Hospital","class":"OTHER"},{"name":"HaiyanPeople's hospital","class":"UNKNOWN"},{"name":"Wenzhou Central Hospital","class":"OTHER"},{"name":"The Central Hospital of Lishui City","class":"OTHER"},{"name":"Dongyang People's Hospital","class":"OTHER_GOV"},{"name":"Rui'an People's hospital","class":"UNKNOWN"}]},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study was aimed at patients with newly diagnosed stroke / TIA associated with nonvalvular atrial fibrillation. We will observe the effect of early using rivaroxaban anticoagulation on hemorrhagic transformation, and explore the predictive value of multi-mode MRI infarct volume / MMP-9 on hemorrhagic transformation after anticoagulation therapy."},"conditionsModule":{"conditions":["Cerebrovascular Stroke","Intracranial Hemorrhages","Anticoagulant","Matrix Metalloproteinases"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":400,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"DRUG","name":"Rivaroxaban","description":"new oral anticoagulant molecules which is the selective factor Xa inhibitor"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Susceptibility weighted imaging(SWI) detection of newly developed hemorrhagic transformation after 14 days of rivaroxaban treatment","timeFrame":"14 days after enrolling"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Male or female, ageâ‰¥18;\n2. Were newly diagnosed asischemic stroke/TIA concomitant NVAF;\n3. Prescribedand accept Rivaroxaban;\n4. Sign thewritten informed consent.\n\nExclusion Criteria:\n\n1. Renal impairment (CrCl\\<15 ml/min) or severe hepatic impairment.\n2. Significant hemorrhagic transformation (parenchymal hematoma type I or type II by the ECASS definition).\n3. Stroke or TIA caused by large artery atherosclerosis\n4. Planned major surgery or invasive intervention\n5. Active internal bleeding\n6. Malignancy or other serious medical conditions with a life expectancy \\<6 months\n7. Allergery to Rivaroxaban\n8. Pregnancy or breast-feeding","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Newly diagnosed ischemic stroke/TIA patients with NVAF who sign the informed consent and receiveRivaroxaban treatment in the in-patient ward.","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Min Lou, PhD","role":"CONTACT","phone":"13958007213","email":"loumingxc@vip.sina.com"}],"overallOfficials":[{"name":"Min Lou, PhD","affiliation":"Second Affiliated Hospital, School of Medicine, Zhejiang University","role":"STUDY_CHAIR"}],"locations":[{"facility":"Second Affiliated Hospital, School of Medicine, Zhejiang University","status":"RECRUITING","city":"Hangzhou","state":"Zhejiang","zip":"310009","country":"China","contacts":[{"name":"MIN LOU, Ph.D.","role":"CONTACT","phone":"8657187784811","email":"loumingxc@vip.sina.com"},{"name":"MIN LOU, Ph.D.","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":30.29365,"lon":120.16142}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000020300","term":"Intracranial Hemorrhages"},{"id":"D000001281","term":"Atrial Fibrillation"},{"id":"D000007238","term":"Infarction"},{"id":"D000006470","term":"Hemorrhage"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000007511","term":"Ischemia"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M9246","name":"Hemorrhage","asFound":"Hemorrhage","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M9972","name":"Infarction","asFound":"Infarction","relevance":"HIGH"},{"id":"M21803","name":"Intracranial Hemorrhages","asFound":"Intracranial Hemorrhage","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000069552","term":"Rivaroxaban"}],"ancestors":[{"id":"D000065427","term":"Factor Xa Inhibitors"},{"id":"D000000991","term":"Antithrombins"},{"id":"D000015842","term":"Serine Proteinase Inhibitors"},{"id":"D000011480","term":"Protease Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000000925","term":"Anticoagulants"}],"browseLeaves":[{"id":"M3934","name":"Anticoagulants","relevance":"LOW"},{"id":"M30203","name":"Factor Xa Inhibitors","relevance":"LOW"},{"id":"M463","name":"Rivaroxaban","asFound":"Weight loss","relevance":"HIGH"},{"id":"M3997","name":"Antithrombins","relevance":"LOW"},{"id":"M3996","name":"Antithrombin III","relevance":"LOW"},{"id":"M14033","name":"Protease Inhibitors","relevance":"LOW"},{"id":"M18081","name":"Serine Proteinase Inhibitors","relevance":"LOW"},{"id":"M19299","name":"HIV Protease Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"T18","name":"Serine","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnCoag","name":"Anticoagulants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Infe","name":"Anti-Infective Agents"},{"abbrev":"AA","name":"Amino Acids"}]}},"hasResults":false}